The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine | npj Vaccines
Cells | Free Full-Text | New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond | HTML
HLA-E and NKG2A as a novel immune checkpoint axis to improve treatment for non-muscle invasive bladder cancer | Horowitz Laboratory
Role of urothelial cells in BCG immunotherapy for superficial bladder cancer | British Journal of Cancer
Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: Molecular Mechanisms of Action | Bentham Science
Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer | Nature Reviews Urology
Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer | Oncotarget
Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes - ScienceDirect
Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin - European Urology
Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer | Semantic Scholar
Frontiers | Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer | Pharmacology
Mechanisms of immune evasion in bladder cancer | SpringerLink
Proposed mechanism of action of MCNA. IN addition to an... | Download Scientific Diagram
Use of bacille Calmette-Guérin in superficial bladder cancer | Postgraduate Medical Journal
The battle field between BCG and Immune cells: The mechanism of... | Download Scientific Diagram
Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model - ScienceDirect
The mechanism of action of BCG therapy for bladder cancer—a current perspective | Semantic Scholar
Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An U | ITT
Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette–Guérin | Future Oncology
The Role of Interleukin-10 in Suppression of Bacillus Calmette-Guérin Induced T Helper Type 1Immune Response and Anti-Bladder Cancer Immunity
Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-invasive Bladder Cancer in Intermediate- and High-risk Patients: Final Outcome of
Bladder Ca biomarkers and BCG: New knowledge of the urinary microbiome
Investigating the STING Pathway to Explain Mechanisms of BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications - IOS Press
Treatment of non-muscle invasive bladder cancer with Bacillus Calmette–Guerin (BCG): Biological markers and simulation studies - ScienceDirect
Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect - ScienceDirect
